Longview Acquisition II EBIT 2021-2022 | LGV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Longview Acquisition II ebit from 2021 to 2022. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Longview Acquisition II ebit from 2021 to 2022. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$216.7B
Thermo Fisher Scientific (TMO)	$203.1B
Alcon (ALC)	$44.2B
Edwards Lifesciences (EW)	$44B
IDEXX Laboratories (IDXX)	$36.9B
DexCom (DXCM)	$35B
IQVIA Holdings (IQV)	$34.6B
Mettler-Toledo (MTD)	$27.3B
Waters (WAT)	$22.4B
STERIS (STE)	$21.8B
SONOVA HOLDING (SONVY)	$19.6B
Hologic (HOLX)	$14.4B
Fresenius Medical Care AG KGaA (FMS)	$13.6B
Penumbra (PEN)	$11.7B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$11.5B
Masimo (MASI)	$9.6B
Glaukos (GKOS)	$8.9B
Teleflex (TFX)	$8.1B
Integer Holdings (ITGR)	$4.8B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$3.5B
Veracyte (VCYT)	$3.3B
Nihon Kohden (NHNKY)	$2.7B
TransMedics (TMDX)	$2.7B
LivaNova (LIVN)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
Alphatec Holdings (ATEC)	$1.5B